Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,217 | 928 | 249 | 150 | 50 |
| Income taxes - deferred | 0 | -133 | -185 | N/A | N/A |
| Accounts receivable | -1,063 | -791 | -562 | -219 | -223 |
| Accounts payable and accrued liabilities | 2,260 | 597 | 61 | -852 | -83 |
| Other Working Capital | 593 | -1,512 | -505 | -836 | -711 |
| Other Operating Activity | -10,450 | -5,137 | -2,417 | -1,303 | -1,268 |
| Operating Cash Flow | $-7,443 | $-6,049 | $-3,358 | $-3,061 | $-2,235 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,457 | -2,856 | -4,738 | -1,077 | -642 |
| Net Acquisitions | -10,000 | -24,634 | -2,000 | -4,002 | -10,220 |
| Purchase Sale Intangibles | 0 | 0 | -5 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -250 | -196 |
| Investing Cash Flow | $-12,457 | $-27,490 | $-6,743 | $-5,329 | $-11,058 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -34 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 0 | 16,800 | 33,000 | 0 | 0 |
| Other Financing Activity | 164 | -89 | 22,082 | 30,091 | -45 |
| Financing Cash Flow | $130 | $16,711 | $55,082 | $30,091 | $-45 |
| Beginning Cash Position | 72,676 | 89,504 | 44,523 | 22,822 | 36,160 |
| End Cash Position | 52,905 | 72,676 | 89,504 | 44,523 | 22,822 |
| Net Cash Flow | $-19,771 | $-16,827 | $44,980 | $21,701 | $-13,338 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,443 | -6,049 | -3,358 | -3,061 | -2,235 |
| Capital Expenditure | -2,457 | -2,856 | -4,743 | -1,077 | -642 |
| Free Cash Flow | -9,901 | -8,904 | -8,101 | -4,138 | -2,877 |